Recognizing the True Cost of Medical Spending - An Assessment of Ranibizumab for Retinal Disorders

Steven M. Kymes, David Vollman

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	1432-1433
Number of pages	2
Journal	JAMA Ophthalmology
Volume	137
Issue number	12
DOIs	https://doi.org/10.1001/jamaophthalmol.2019.4275
State	Published - Dec 2019

Access to Document

@article{2da5c93483dd48a9b0758196de4afb3a,

title = "Recognizing the True Cost of Medical Spending - An Assessment of Ranibizumab for Retinal Disorders",

author = "Kymes, {Steven M.} and David Vollman",

year = "2019",

month = dec,

doi = "10.1001/jamaophthalmol.2019.4275",

language = "English",

volume = "137",

pages = "1432--1433",

journal = "JAMA Ophthalmology",

issn = "2168-6165",

number = "12",

}

TY - JOUR

T1 - Recognizing the True Cost of Medical Spending - An Assessment of Ranibizumab for Retinal Disorders

AU - Kymes, Steven M.

AU - Vollman, David

PY - 2019/12

Y1 - 2019/12

UR - http://www.scopus.com/inward/record.url?scp=85074203370&partnerID=8YFLogxK

U2 - 10.1001/jamaophthalmol.2019.4275

DO - 10.1001/jamaophthalmol.2019.4275

M3 - Comment/debate

C2 - 31647498

AN - SCOPUS:85074203370

SN - 2168-6165

VL - 137

SP - 1432

EP - 1433

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

IS - 12

ER -